GroundRules
Browse Federal regulations
Read the original sections, or search by topic.
- 21 CFR 522.2444a · a Thiopental powder for injection.
- 21 CFR 522.2444b · b Thiopental and pentobarbital powder for injection.
- 21 CFR 522.2450 · Tigilanol.
- 21 CFR 522.2460 · Tildipirosin.
- 21 CFR 522.2470 · Tiletamine and zolazepam.
- 21 CFR 522.2471 · Tilmicosin.
- 21 CFR 522.2473 · Tiludronate.
- 21 CFR 522.2474 · Tolazoline.
- 21 CFR 522.2476 · Trenbolone acetate.
- 21 CFR 522.2477 · Trenbolone acetate and estradiol.
- 21 CFR 522.2478 · Trenbolone acetate and estradiol benzoate.
- 21 CFR 522.2483 · Triamcinolone.
- 21 CFR 522.2582 · Triflupromazine.
- 21 CFR 522.2610 · Trimethoprim and sulfadiazine.
- 21 CFR 522.2615 · Tripelennamine.
- 21 CFR 522.2630 · Tulathromycin.
- 21 CFR 522.2632 · Tulathromycin and ketoprofen.
- 21 CFR 522.2640 · Tylosin.
- 21 CFR 522.2662 · Xylazine.
- 21 CFR 522.2670 · Yohimbine.
- 21 CFR 522.2680 · Zeranol.
- 21 CFR 522.2690 · Zinc gluconate.
- 21 CFR 522.2694 · Zinc, copper, manganese, and selenium.
- 21 CFR 524.86 · Amitraz.
- 21 CFR 524.154 · Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
- 21 CFR 524.155 · Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
- 21 CFR 524.230 · Buprenorphine.
- 21 CFR 524.390 · Chloramphenicol ophthalmic ointment.
- 21 CFR 524.402 · Chlorhexidine.
- 21 CFR 524.450 · Clotrimazole.
- 21 CFR 524.463 · Copper naphthenate.
- 21 CFR 524.575 · Cyclosporine ophthalmic ointment.
- 21 CFR 524.590 · Diclofenac.
- 21 CFR 524.660 · Dimethyl sulfoxide.
- 21 CFR 524.770 · Doramectin.
- 21 CFR 524.775 · Emodepside and praziquantel.
- 21 CFR 524.802 · Enrofloxacin and silver sulfadiazine otic emulsion.
- 21 CFR 524.814 · Eprinomectin.
- 21 CFR 524.815 · Eprinomectin and praziquantel.
- 21 CFR 524.838 · Esafoxolaner, eprinomectin, and praziquantel.
- 21 CFR 524.900 · Famphur.
- 21 CFR 524.920 · Fenthion.
- 21 CFR 524.955 · Florfenicol, terbinafine, and betamethasone acetate otic gel.
- 21 CFR 524.957 · Florfenicol, terbinafine, and mometasone otic solution.
- 21 CFR 524.960 · Flumethasone, neomycin, and polymyxin B ophthalmic solution.
- 21 CFR 524.970 · Flunixin.
- 21 CFR 524.981 · [Reserved]
- 21 CFR 524.981a · a Fluocinolone cream.
- 21 CFR 524.981b · b Fluocinolone solution.
- 21 CFR 524.981c · c Fluocinolone and neomycin cream.
- 21 CFR 524.981d · d Fluocinolone and dimethyl sulfoxide solution.
- 21 CFR 524.981e · e Fluocinolone and dimethyl sulfoxide otic solution.
- 21 CFR 524.998 · Fluralaner.
- 21 CFR 524.1001 · Fluralaner and moxidectin.
- 21 CFR 524.1005 · Furazolidone powder.
- 21 CFR 524.1044 · Gentamicin ophthalmic and topical dosage forms.
- 21 CFR 524.1044a · a Gentamicin ophthalmic solution.
- 21 CFR 524.1044b · b Gentamicin and betamethasone otic solution.
- 21 CFR 524.1044c · c Gentamicin ophthalmic ointment.
- 21 CFR 524.1044d · d Gentamicin and betamethasone ointment.
- 21 CFR 524.1044e · e Gentamicin spray.
- 21 CFR 524.1044f · f Gentamicin and betamethasone spray.
- 21 CFR 524.1044g · g Gentamicin, betamethasone, and clotrimazole ointment.
- 21 CFR 524.1044h · h Gentamicin, mometasone, and clotrimazole otic suspension.
- 21 CFR 524.1044i · i Gentamicin and betamethasone ophthalmic solution.
- 21 CFR 524.1132 · Hydrocortisone, miconazole, and gentamicin otic suspension.
- 21 CFR 524.1140 · Imidacloprid and ivermectin.
- 21 CFR 524.1144j · j Gentamicin, posaconazole, and mometasone furoate otic suspension.
- 21 CFR 524.1146 · Imidacloprid and moxidectin.
- 21 CFR 524.1193 · Ivermectin topical solution.
- 21 CFR 524.1195 · Ivermectin otic suspension.
- 21 CFR 524.1200 · Kanamycin ophthalmic and topical dosage forms.
- 21 CFR 524.1200a · a Kanamycin ophthalmic ointment.
- 21 CFR 524.1200b · b Kanamycin ophthalmic solution.
- 21 CFR 524.1204 · Kanamycin, amphomycin, and hydrocortisone ointment.
- 21 CFR 524.1240 · Levamisole.
- 21 CFR 524.1312 · Marbofloxacin, terbinafine, and dexamethasone otic suspension.
- 21 CFR 524.1376 · 2-Mercaptobenzothiazole solution.
- 21 CFR 524.1443 · Miconazole.
- 21 CFR 524.1445 · Miconazole, polymixin B, and prednisolone suspension.
- 21 CFR 524.1446 · Milbemycin otic solution.
- 21 CFR 524.1448 · Mirtazapine transdermal ointment.
- 21 CFR 524.1450 · Moxidectin.
- 21 CFR 524.1465 · Mupirocin.
- 21 CFR 524.1484 · Neomycin ophthalmic and topical dosage forms.
- 21 CFR 524.1484b · b Neomycin, isoflupredone, and tetracaine powder.
- 21 CFR 524.1484c · c Neomycin, isoflupredone, and tetracaine ointment.
- 21 CFR 524.1484d · d Neomycin, hydrocortisone, and tetracaine otic ointment.
- 21 CFR 524.1484e · e Neomycin and polymyxin B ophthalmic solution.
- 21 CFR 524.1484f · f Neomycin, prednisolone, and tetracaine otic suspension.
- 21 CFR 524.1484g · g Neomycin, thiabendazole, and dexamethasone solution.
- 21 CFR 524.1484h · h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
- 21 CFR 524.1484i · i Neomycin and hydrocortisone ointment.
- 21 CFR 524.1484k · k Neomycin and prednisolone suspension.
- 21 CFR 524.1580 · Nitrofurazone topical dosage forms.
- 21 CFR 524.1580a · a Nitrofurazone ointment.
- 21 CFR 524.1580b · b Nitrofurazone soluble powder.
- 21 CFR 524.1600 · Nystatin ophthalmic and topical dosage forms.
- 21 CFR 524.1600a · a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
- 21 CFR 524.1600b · b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.